Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Neurodegenerative Disorder Therapeutics industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Novartis AG
Merck KGaA
Sanofi SA
AbbVie Inc
Teva Pharmaceutical Industries Ltd
F Hoffmann- La Roche Ltd
Bayer AG
GlaxoSmithKline PLC
Pfizer Inc
UCB SA
H Lundbeck
Eisai CO LTD
Boehringer Ingeiheim International GmbH
By Type:
Immunomodulators
Dopamine Agonists
Decarboxylase Inhibitors
Interferons
Others
By Application:
Parkinson'S Disease
Huntington Disease
Alzheimer'S Disease
Spinal Muscular Atrophy
Multiple Sclerosis
Other Neurodegenerative Disorders
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Neurodegenerative Disorder Therapeutics Market Overview 2018-2029
-
1.1 China Neurodegenerative Disorder Therapeutics Industry Development Overview
-
1.2 China Neurodegenerative Disorder Therapeutics Industry Development History
-
1.3 China Neurodegenerative Disorder Therapeutics Industry Market Size (2018-2029)
-
1.4 China Neurodegenerative Disorder Therapeutics Market Analysis by Type from Production Side
-
1.4.1 China Neurodegenerative Disorder Therapeutics Production Volume, Production Value and Growth Rate of Immunomodulators (2018-2029)
-
1.4.2 China Neurodegenerative Disorder Therapeutics Production Volume, Production Value and Growth Rate of Dopamine Agonists (2018-2029)
-
1.4.3 China Neurodegenerative Disorder Therapeutics Production Volume, Production Value and Growth Rate of Decarboxylase Inhibitors (2018-2029)
-
1.4.4 China Neurodegenerative Disorder Therapeutics Production Volume, Production Value and Growth Rate of Interferons (2018-2029)
-
1.4.5 China Neurodegenerative Disorder Therapeutics Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.5 China Neurodegenerative Disorder Therapeutics Market Analysis by Application from Consumption End
-
1.5.1 China Neurodegenerative Disorder Therapeutics Sales Volume, Sales Value and Growth Rate of Parkinson'S Disease (2018-2029)
-
1.5.2 China Neurodegenerative Disorder Therapeutics Sales Volume, Sales Value and Growth Rate of Huntington Disease (2018-2029)
-
1.5.3 China Neurodegenerative Disorder Therapeutics Sales Volume, Sales Value and Growth Rate of Alzheimer'S Disease (2018-2029)
-
1.5.4 China Neurodegenerative Disorder Therapeutics Sales Volume, Sales Value and Growth Rate of Spinal Muscular Atrophy (2018-2029)
-
1.5.5 China Neurodegenerative Disorder Therapeutics Sales Volume, Sales Value and Growth Rate of Multiple Sclerosis (2018-2029)
-
1.5.6 China Neurodegenerative Disorder Therapeutics Sales Volume, Sales Value and Growth Rate of Other Neurodegenerative Disorders (2018-2029)
-
1.6 China Neurodegenerative Disorder Therapeutics Market Analysis by Region
-
1.6.1 North China Neurodegenerative Disorder Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Neurodegenerative Disorder Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Neurodegenerative Disorder Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Neurodegenerative Disorder Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Neurodegenerative Disorder Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Neurodegenerative Disorder Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Neurodegenerative Disorder Therapeutics Market Size and Growth Rate from 2018-2029
Chapter 2 China Neurodegenerative Disorder Therapeutics Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Neurodegenerative Disorder Therapeutics Market Status and Competition at home and abroad in 2023
-
2.2.2 China Neurodegenerative Disorder Therapeutics Market Status and Competition Analysis in 2023
-
2.2.3 China Neurodegenerative Disorder Therapeutics Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Neurodegenerative Disorder Therapeutics Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Neurodegenerative Disorder Therapeutics Industry Development
Chapter 3 Neurodegenerative Disorder TherapeuticsIndustry Chain Analysis
-
3.1 Neurodegenerative Disorder Therapeutics Industry Chain
-
3.2 Neurodegenerative Disorder Therapeutics Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Neurodegenerative Disorder Therapeutics Market
-
3.3 Neurodegenerative Disorder Therapeutics Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Neurodegenerative Disorder Therapeutics Market
Chapter 4 China Neurodegenerative Disorder Therapeutics Market, by Type
-
4.1 China Neurodegenerative Disorder Therapeutics Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Neurodegenerative Disorder Therapeutics Total Production Volume and Growth Rate from Production Side
-
4.5 China Neurodegenerative Disorder Therapeutics Production Volume and Growth Rate, by Type
-
4.5.1 China Neurodegenerative Disorder Therapeutics Production Volume and Growth Rate of Immunomodulators
-
4.5.2 China Neurodegenerative Disorder Therapeutics Production Volume and Growth Rate of Dopamine Agonists
-
4.5.3 China Neurodegenerative Disorder Therapeutics Production Volume and Growth Rate of Decarboxylase Inhibitors
-
4.5.4 China Neurodegenerative Disorder Therapeutics Production Volume and Growth Rate of Interferons
-
4.5.5 China Neurodegenerative Disorder Therapeutics Production Volume and Growth Rate of Others
Chapter 5 China Neurodegenerative Disorder Therapeutics Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Neurodegenerative Disorder Therapeutics Total Market Size and Growth Rate from Consumption End
-
5.5 China Neurodegenerative Disorder Therapeutics Market Size and Growth Rate, by Application
-
5.5.1 China Neurodegenerative Disorder Therapeutics Market Size and Growth Rate of Parkinson'S Disease
-
5.5.2 China Neurodegenerative Disorder Therapeutics Market Size and Growth Rate of Huntington Disease
-
5.5.3 China Neurodegenerative Disorder Therapeutics Market Size and Growth Rate of Alzheimer'S Disease
-
5.5.4 China Neurodegenerative Disorder Therapeutics Market Size and Growth Rate of Spinal Muscular Atrophy
-
5.5.5 China Neurodegenerative Disorder Therapeutics Market Size and Growth Rate of Multiple Sclerosis
-
5.5.6 China Neurodegenerative Disorder Therapeutics Market Size and Growth Rate of Other Neurodegenerative Disorders
Chapter 6 China Neurodegenerative Disorder Therapeutics Market, by Region
-
6.1 China Neurodegenerative Disorder Therapeutics Production Volume and Production Value, by Region
-
6.2 China Neurodegenerative Disorder Therapeutics Sales Volume and Sales Value, by Region
Chapter 7 North China Neurodegenerative Disorder Therapeutics Market Analysis
-
7.1 North China Neurodegenerative Disorder Therapeutics Market, by Type
-
7.2 North China Neurodegenerative Disorder Therapeutics Market, by Application
Chapter 8 Central China Neurodegenerative Disorder Therapeutics Market Analysis
-
8.1 Central China Neurodegenerative Disorder Therapeutics Market, by Type
-
8.2 Central China Neurodegenerative Disorder Therapeutics Market, by Application
Chapter 9 South China Neurodegenerative Disorder Therapeutics Market Analysis
-
9.1 South China Neurodegenerative Disorder Therapeutics Market, by Type
-
9.2 South China Neurodegenerative Disorder Therapeutics Market, by Application
Chapter 10 East China Neurodegenerative Disorder Therapeutics Market Analysis
-
10.1 East China Neurodegenerative Disorder Therapeutics Market, by Type
-
10.2 East China Neurodegenerative Disorder Therapeutics Market, by Application
Chapter 11 Northeast China Neurodegenerative Disorder Therapeutics Market Analysis
-
11.1 Northeast China Neurodegenerative Disorder Therapeutics Market, by Type
-
11.2 Northeast China Neurodegenerative Disorder Therapeutics Market, by Application
Chapter 12 Southwest China Neurodegenerative Disorder Therapeutics Market Analysis
-
12.1 Southwest China Neurodegenerative Disorder Therapeutics Market, by Type
-
12.2 Southwest China Neurodegenerative Disorder Therapeutics Market, by Application
Chapter 13 Northwest China Neurodegenerative Disorder Therapeutics Market Analysis
-
13.1 Northwest China Neurodegenerative Disorder Therapeutics Market, by Type
-
13.2 Northwest China Neurodegenerative Disorder Therapeutics Market, by Application
Chapter 14 Company Profiles
-
14.1 Novartis AG
-
14.1.1 Novartis AG Company Profile
-
14.1.2 Novartis AG Neurodegenerative Disorder Therapeutics Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Merck KGaA
-
14.2.1 Merck KGaA Company Profile
-
14.2.2 Merck KGaA Neurodegenerative Disorder Therapeutics Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Sanofi SA
-
14.3.1 Sanofi SA Company Profile
-
14.3.2 Sanofi SA Neurodegenerative Disorder Therapeutics Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 AbbVie Inc
-
14.4.1 AbbVie Inc Company Profile
-
14.4.2 AbbVie Inc Neurodegenerative Disorder Therapeutics Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Teva Pharmaceutical Industries Ltd
-
14.5.1 Teva Pharmaceutical Industries Ltd Company Profile
-
14.5.2 Teva Pharmaceutical Industries Ltd Neurodegenerative Disorder Therapeutics Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 F Hoffmann- La Roche Ltd
-
14.6.1 F Hoffmann- La Roche Ltd Company Profile
-
14.6.2 F Hoffmann- La Roche Ltd Neurodegenerative Disorder Therapeutics Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Bayer AG
-
14.7.1 Bayer AG Company Profile
-
14.7.2 Bayer AG Neurodegenerative Disorder Therapeutics Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 GlaxoSmithKline PLC
-
14.8.1 GlaxoSmithKline PLC Company Profile
-
14.8.2 GlaxoSmithKline PLC Neurodegenerative Disorder Therapeutics Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Pfizer Inc
-
14.9.1 Pfizer Inc Company Profile
-
14.9.2 Pfizer Inc Neurodegenerative Disorder Therapeutics Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 UCB SA
-
14.10.1 UCB SA Company Profile
-
14.10.2 UCB SA Neurodegenerative Disorder Therapeutics Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 H Lundbeck
-
14.11.1 H Lundbeck Company Profile
-
14.11.2 H Lundbeck Neurodegenerative Disorder Therapeutics Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Eisai CO LTD
-
14.12.1 Eisai CO LTD Company Profile
-
14.12.2 Eisai CO LTD Neurodegenerative Disorder Therapeutics Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Boehringer Ingeiheim International GmbH
-
14.13.1 Boehringer Ingeiheim International GmbH Company Profile
-
14.13.2 Boehringer Ingeiheim International GmbH Neurodegenerative Disorder Therapeutics Market Performance
-
14.13.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Neurodegenerative Disorder Therapeutics Industry Research Conclusions
-
15.2 Neurodegenerative Disorder Therapeutics Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Neurodegenerative Disorder Therapeutics Industry Market Size (2018-2029)
-
Figure China Neurodegenerative Disorder Therapeutics Production Volume, Production Value and Growth Rate of Immunomodulators (2018-2029)
-
Figure China Neurodegenerative Disorder Therapeutics Production Volume, Production Value and Growth Rate of Dopamine Agonists (2018-2029)
-
Figure China Neurodegenerative Disorder Therapeutics Production Volume, Production Value and Growth Rate of Decarboxylase Inhibitors (2018-2029)
-
Figure China Neurodegenerative Disorder Therapeutics Production Volume, Production Value and Growth Rate of Interferons (2018-2029)
-
Figure China Neurodegenerative Disorder Therapeutics Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Neurodegenerative Disorder Therapeutics Sales Volume, Sales Value and Growth Rate of Parkinson'S Disease (2018-2029)
-
Figure China Neurodegenerative Disorder Therapeutics Sales Volume, Sales Value and Growth Rate of Huntington Disease (2018-2029)
-
Figure China Neurodegenerative Disorder Therapeutics Sales Volume, Sales Value and Growth Rate of Alzheimer'S Disease (2018-2029)
-
Figure China Neurodegenerative Disorder Therapeutics Sales Volume, Sales Value and Growth Rate of Spinal Muscular Atrophy (2018-2029)
-
Figure China Neurodegenerative Disorder Therapeutics Sales Volume, Sales Value and Growth Rate of Multiple Sclerosis (2018-2029)
-
Figure China Neurodegenerative Disorder Therapeutics Sales Volume, Sales Value and Growth Rate of Other Neurodegenerative Disorders (2018-2029)
-
Figure North China Neurodegenerative Disorder Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Central China Neurodegenerative Disorder Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure South China Neurodegenerative Disorder Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure East China Neurodegenerative Disorder Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Neurodegenerative Disorder Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Neurodegenerative Disorder Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Neurodegenerative Disorder Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Neurodegenerative Disorder Therapeutics Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Neurodegenerative Disorder Therapeutics Market Share by Type in 2018
-
Figure China Neurodegenerative Disorder Therapeutics Market Share by Type in 2023
-
Figure China Neurodegenerative Disorder Therapeutics Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Neurodegenerative Disorder Therapeutics Production Volume and Growth Rate of Immunomodulators (2018-2023)
-
Figure China Neurodegenerative Disorder Therapeutics Production Volume and Growth Rate of Dopamine Agonists (2018-2023)
-
Figure China Neurodegenerative Disorder Therapeutics Production Volume and Growth Rate of Decarboxylase Inhibitors (2018-2023)
-
Figure China Neurodegenerative Disorder Therapeutics Production Volume and Growth Rate of Interferons (2018-2023)
-
Figure China Neurodegenerative Disorder Therapeutics Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Neurodegenerative Disorder Therapeutics Market Share by Application in 2018
-
Figure China Neurodegenerative Disorder Therapeutics Market Share by Application in 2023
-
Figure China Neurodegenerative Disorder Therapeutics Total Market Size and Growth Rate from Consumption End
-
Figure China Neurodegenerative Disorder Therapeutics Market Size and Growth Rate of Parkinson'S Disease (2018-2023)
-
Figure China Neurodegenerative Disorder Therapeutics Market Size and Growth Rate of Huntington Disease (2018-2023)
-
Figure China Neurodegenerative Disorder Therapeutics Market Size and Growth Rate of Alzheimer'S Disease (2018-2023)
-
Figure China Neurodegenerative Disorder Therapeutics Market Size and Growth Rate of Spinal Muscular Atrophy (2018-2023)
-
Figure China Neurodegenerative Disorder Therapeutics Market Size and Growth Rate of Multiple Sclerosis (2018-2023)
-
Figure China Neurodegenerative Disorder Therapeutics Market Size and Growth Rate of Other Neurodegenerative Disorders (2018-2023)
-
Table China Neurodegenerative Disorder Therapeutics Production Volume by Region (2018-2023)
-
Table China Neurodegenerative Disorder Therapeutics Production Volume Share by Region (2018-2023)
-
Figure China Neurodegenerative Disorder Therapeutics Production Volume Share by Region (2018-2023)
-
Table China Neurodegenerative Disorder Therapeutics Production Value by Region (2018-2023)
-
Table China Neurodegenerative Disorder Therapeutics Production Value Share by Region (2018-2023)
-
Figure China Neurodegenerative Disorder Therapeutics Production Value Share by Region (2018-2023)
-
Table China Neurodegenerative Disorder Therapeutics Sales Volume by Region (2018-2023)
-
Table China Neurodegenerative Disorder Therapeutics Sales Volume Share by Region (2018-2023)
-
Figure China Neurodegenerative Disorder Therapeutics Sales Volume Share by Region (2018-2023)
-
Table China Neurodegenerative Disorder Therapeutics Sales Value by Region (2018-2023)
-
Table China Neurodegenerative Disorder Therapeutics Sales Value Share by Region (2018-2023)
-
Figure China Neurodegenerative Disorder Therapeutics Sales Value Share by Region (2018-2023)
-
Table North China Neurodegenerative Disorder Therapeutics Production Volume by Type (2018-2023)
-
Table North China Neurodegenerative Disorder Therapeutics Production Volume Share by Type (2018-2023)
-
Figure North China Neurodegenerative Disorder Therapeutics Production Volume Share by Type (2018-2023)
-
Table North China Neurodegenerative Disorder Therapeutics Sales Volume by Application (2018-2023)
-
Table North China Neurodegenerative Disorder Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure North China Neurodegenerative Disorder Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Central China Neurodegenerative Disorder Therapeutics Production Volume by Type (2018-2023)
-
Table Central China Neurodegenerative Disorder Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Central China Neurodegenerative Disorder Therapeutics Production Volume Share by Type (2018-2023)
-
Table Central China Neurodegenerative Disorder Therapeutics Sales Volume by Application (2018-2023)
-
Table Central China Neurodegenerative Disorder Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Central China Neurodegenerative Disorder Therapeutics Sales Volume Share by Application (2018-2023)
-
Table South China Neurodegenerative Disorder Therapeutics Production Volume by Type (2018-2023)
-
Table South China Neurodegenerative Disorder Therapeutics Production Volume Share by Type (2018-2023)
-
Figure South China Neurodegenerative Disorder Therapeutics Production Volume Share by Type (2018-2023)
-
Table South China Neurodegenerative Disorder Therapeutics Sales Volume by Application (2018-2023)
-
Table South China Neurodegenerative Disorder Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure South China Neurodegenerative Disorder Therapeutics Sales Volume Share by Application (2018-2023)
-
Table East China Neurodegenerative Disorder Therapeutics Production Volume by Type (2018-2023)
-
Table East China Neurodegenerative Disorder Therapeutics Production Volume Share by Type (2018-2023)
-
Figure East China Neurodegenerative Disorder Therapeutics Production Volume Share by Type (2018-2023)
-
Table East China Neurodegenerative Disorder Therapeutics Sales Volume by Application (2018-2023)
-
Table East China Neurodegenerative Disorder Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure East China Neurodegenerative Disorder Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Northeast China Neurodegenerative Disorder Therapeutics Production Volume by Type (2018-2023)
-
Table Northeast China Neurodegenerative Disorder Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Northeast China Neurodegenerative Disorder Therapeutics Production Volume Share by Type (2018-2023)
-
Table Northeast China Neurodegenerative Disorder Therapeutics Sales Volume by Application (2018-2023)
-
Table Northeast China Neurodegenerative Disorder Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Neurodegenerative Disorder Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Southwest China Neurodegenerative Disorder Therapeutics Production Volume by Type (2018-2023)
-
Table Southwest China Neurodegenerative Disorder Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Southwest China Neurodegenerative Disorder Therapeutics Production Volume Share by Type (2018-2023)
-
Table Southwest China Neurodegenerative Disorder Therapeutics Sales Volume by Application (2018-2023)
-
Table Southwest China Neurodegenerative Disorder Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Neurodegenerative Disorder Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Northwest China Neurodegenerative Disorder Therapeutics Production Volume by Type (2018-2023)
-
Table Northwest China Neurodegenerative Disorder Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Northwest China Neurodegenerative Disorder Therapeutics Production Volume Share by Type (2018-2023)
-
Table Northwest China Neurodegenerative Disorder Therapeutics Sales Volume by Application (2018-2023)
-
Table Northwest China Neurodegenerative Disorder Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Neurodegenerative Disorder Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Novartis AG Company Profile
-
Table Novartis AG Neurodegenerative Disorder Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Merck KGaA Company Profile
-
Table Merck KGaA Neurodegenerative Disorder Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Sanofi SA Company Profile
-
Table Sanofi SA Neurodegenerative Disorder Therapeutics Revenue, Price and Gross (2018-2023)
-
Table AbbVie Inc Company Profile
-
Table AbbVie Inc Neurodegenerative Disorder Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Teva Pharmaceutical Industries Ltd Company Profile
-
Table Teva Pharmaceutical Industries Ltd Neurodegenerative Disorder Therapeutics Revenue, Price and Gross (2018-2023)
-
Table F Hoffmann- La Roche Ltd Company Profile
-
Table F Hoffmann- La Roche Ltd Neurodegenerative Disorder Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Bayer AG Company Profile
-
Table Bayer AG Neurodegenerative Disorder Therapeutics Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline PLC Company Profile
-
Table GlaxoSmithKline PLC Neurodegenerative Disorder Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Pfizer Inc Company Profile
-
Table Pfizer Inc Neurodegenerative Disorder Therapeutics Revenue, Price and Gross (2018-2023)
-
Table UCB SA Company Profile
-
Table UCB SA Neurodegenerative Disorder Therapeutics Revenue, Price and Gross (2018-2023)
-
Table H Lundbeck Company Profile
-
Table H Lundbeck Neurodegenerative Disorder Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Eisai CO LTD Company Profile
-
Table Eisai CO LTD Neurodegenerative Disorder Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Boehringer Ingeiheim International GmbH Company Profile
-
Table Boehringer Ingeiheim International GmbH Neurodegenerative Disorder Therapeutics Revenue, Price and Gross (2018-2023)
-
